IP Library Granted Patent US 8,167,836
Granted Patent B2
US 8,167,836 · App. 12/963,621 · Granted May 1, 2012

Tissue expander configured for drug delivery

Assignee: Taris Biomedical, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,167,836
App. No.
12/963,621
Granted
May 1, 2012
Kind
B2
Abstract

A device includes a tissue expanding portion and an enclosure positioned on a surface of the tissue expanding portion. The enclosure includes an enclosure wall and a drug formulation pocket defined by the enclosure wall. A solid drug formulation that includes a drug is housed within the drug formulation pocket.

Claims (32)

1. A tissue expander device comprising:

a tissue expanding portion;

an enclosure positioned on a surface of the tissue expanding portion, the enclosure comprising:

an enclosure wall; and

a drug formulation pocket defined by the enclosure wall; and

a solid drug formulation comprising a drug, the solid drug formulation housed within the drug formulation pocket.

2. The device of claim 1 , wherein the tissue expanding portion comprises:

an expandable balloon which defines a cavity for receiving an inflating fluid;

an injection port; and

a fill tube operable for communicating the inflating fluid from the injection port into the cavity for expanding the balloon from outside of a patient's body after the balloon has been implanted in the body.

3. The device of claim 2 , wherein:

the enclosure wall comprises:

a portion of a wall of the expandable balloon; and

a cover; and

the cover is attached to the portion of the wall of the expandable balloon to define the drug formulation pocket.

4. The device of a claim 3 , wherein:

the cover is attached to an exterior surface of the wall of the expandable balloon;

the expandable balloon is substantially impermeable to water and the drug; and

the cover is permeable to water.

5. The device of claim 4 , wherein the cover comprises one or more of the following: an aperture for releasing the drug and a material that is permeable to the drug for releasing the drug.

6. The device of claim 1 , wherein at least a portion of the enclosure wall comprises a water-permeable material.

7. The device of claim 6 , wherein the enclosure wall comprises an aperture that provides egress for the drug from the pocket.

8. The device of claim 1 , wherein at least a portion of the enclosure wall comprises a material that is permeable to the drug.

9. The device of claim 1 , wherein at least a portion of the enclosure wall comprises silicone.

10. The device of claim 1 , wherein the drug formulation substantially fills the drug formulation pocket.

11. The device of claim 1 , wherein the drug comprises at least one local anesthetic agent.

12. The device of claim 1 , wherein the drug comprises lidocaine.

13. The device of claim 1 , wherein the solid drug formulation comprises a resorbable polymer matrix.

14. A method of treating pain associated with tissue expansion in a patient, comprising:

implanting the tissue expander device of claim 1 in the patient;

expanding the tissue expander portion; and

releasing an effective amount of an analgesic or anesthetic drug from the drug delivery portion for an extended period.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 15, 2014
From: LIRIS BIOMEDICAL, INC.
To: TARIS BIOMEDICAL LLC
Reel/Frame 033742/0538 →
CHANGE OF NAME Recorded Sep 15, 2014
From: TARIS BIOMEDICAL, INC.
To: LIRIS BIOMEDICAL, INC.
Reel/Frame 033744/0938 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 1, 2011
From: LEE, HEEJIN; DANIEL, KAREN; KIM, GRACE; LARRIVEE-ELKINS, CHERYL; CIMA, MICHAEL J.
To: TARIS BIOMEDICAL, INC.
Reel/Frame 025729/0663 →
Continuity (2)
Provisional Application 61267518 · Dec 8, 2009
Related Publication 20110137244A1 · Jun 9, 2011